RMAM
Raab & Moskowitz Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Sell |
4,693
-110
| -2% | -$7.21K | 0.07% | 164 |
|
|
2025
Q1 | $339K | Buy |
4,803
+204
| +4% | +$14.4K | 0.09% | 151 |
|
|
2024
Q4 | $302K | Hold |
4,599
| – | – | 0.07% | 152 |
|
|
2024
Q3 | $325K | Hold |
4,599
| – | – | 0.08% | 149 |
|
|
2024
Q2 | $305K | Hold |
4,599
| – | – | 0.08% | 145 |
|
|
2024
Q1 | $312K | Buy |
4,599
+2,854
| +164% | +$194K | 0.09% | 146 |
|
|
2023
Q4 | $324K | Buy |
1,745
+208
| +14% | +$38.6K | 0.1% | 135 |
|
|
2023
Q3 | $272K | Hold |
1,537
| – | – | 0.1% | 143 |
|
|
2023
Q2 | $275K | Hold |
1,537
| – | – | 0.09% | 141 |
|
|
2023
Q1 | $269K | Hold |
1,537
| – | – | 0.1% | 139 |
|
|
2022
Q4 | $286K | Hold |
1,537
| – | – | 0.11% | 135 |
|
|
2022
Q3 | $260K | Sell |
1,537
-7
| -0.5% | -$1.18K | 0.11% | 138 |
|
|
2022
Q2 | $295K | Sell |
1,544
-28
| -2% | -$5.35K | 0.12% | 134 |
|
|
2022
Q1 | $305K | Sell |
1,572
-219
| -12% | -$42.5K | 0.1% | 138 |
|
|
2021
Q4 | $358K | Sell |
1,791
-6
| -0.3% | -$1.2K | 0.12% | 131 |
|
|
2021
Q3 | $329K | Hold |
1,797
| – | – | 0.12% | 129 |
|
|
2021
Q2 | $334K | Sell |
1,797
-339
| -16% | -$63K | 0.12% | 128 |
|
|
2021
Q1 | $379K | Sell |
2,136
-58
| -3% | -$10.3K | 0.15% | 111 |
|
|
2020
Q4 | $393K | Sell |
2,194
-39
| -2% | -$6.99K | 0.16% | 110 |
|
|
2020
Q3 | $365K | Sell |
2,233
-451
| -17% | -$73.7K | 0.17% | 106 |
|
|
2020
Q2 | $413K | Sell |
2,684
-445
| -14% | -$68.5K | 0.2% | 101 |
|
|
2020
Q1 | $421K | Sell |
3,129
-62
| -2% | -$8.34K | 0.23% | 93 |
|
|
2019
Q4 | $510K | Sell |
3,191
-15
| -0.5% | -$2.4K | 0.2% | 104 |
|
|
2019
Q3 | $448K | Hold |
3,206
| – | – | 0.2% | 112 |
|
|
2019
Q2 | $483K | Sell |
3,206
-99
| -3% | -$14.9K | 0.21% | 106 |
|
|
2019
Q1 | $508K | Sell |
3,305
-65
| -2% | -$9.99K | 0.23% | 101 |
|
|
2018
Q4 | $474K | Sell |
3,370
-35
| -1% | -$4.92K | 0.23% | 99 |
|
|
2018
Q3 | $571K | Sell |
3,405
-75
| -2% | -$12.6K | 0.24% | 98 |
|
|
2018
Q2 | $526K | Sell |
3,480
-77
| -2% | -$11.6K | 0.25% | 103 |
|
|
2018
Q1 | $524K | Buy |
3,557
+17
| +0.5% | +$2.5K | 0.26% | 101 |
|
|
2017
Q4 | $546K | Buy |
3,540
+212
| +6% | +$32.7K | 0.26% | 94 |
|
|
2017
Q3 | $501K | Hold |
3,328
| – | – | 0.24% | 101 |
|
|
2017
Q2 | $491K | Buy |
3,328
+1,716
| +106% | +$253K | 0.24% | 101 |
|
|
2017
Q1 | $243K | Sell |
1,612
-626
| -28% | -$94.4K | 0.13% | 125 |
|
|
2016
Q4 | $316K | Buy |
2,238
+64
| +3% | +$9.04K | 0.17% | 120 |
|
|
2016
Q3 | $324K | Buy |
+2,174
| New | +$324K | 0.18% | 117 |
|
|
2015
Q1 | – | Sell |
-460
| Closed | -$70K | – | 241 |
|
|
2014
Q4 | $70K | Buy |
+460
| New | +$70K | 0.04% | 169 |
|